Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinguishing features of Long COVID identified through immune profiling
Jon Klein, Jamie Wood, Jillian R. Jaycox, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2794
The neurobiology of long COVID
Michelle Monje, Akiko Iwasaki
Neuron (2022) Vol. 110, Iss. 21, pp. 3484-3496
Open Access | Times Cited: 299
The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 266
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 186
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 3
Open Access | Times Cited: 155
Humoral Innate Immunity and Acute-Phase Proteins
Alberto Mantovani, Cecília Garlanda
New England Journal of Medicine (2023) Vol. 388, Iss. 5, pp. 439-452
Open Access | Times Cited: 148
Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics
Albert Leng, Manuj Shah, Syed A. Ahmad, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 816-816
Open Access | Times Cited: 121
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
Arneaux Kruger, Maré Vlok, Simone Turner, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 118
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 100
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 92
Why we need a deeper understanding of the pathophysiology of long COVID
Akiko Iwasaki, David Putrino
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 4, pp. 393-395
Open Access | Times Cited: 88
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
Matthew C. Woodruff, Kevin S. Bonham, Fabliha A. Anam, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 86
Persistent serum protein signatures define an inflammatory subcategory of long COVID
Aarthi Talla, Suhas Vasaikar, Gregory L. Szeto, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 64
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 63
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update
Sizhen Su, Yi‐Miao Zhao, Na Zeng, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4056-4069
Closed Access | Times Cited: 62
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 60
Thromboinflammation in long COVID—the elusive key to postinfection sequelae?
Leo Nicolai, Rainer Kaiser, Konstantin Stark
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 8, pp. 2020-2031
Open Access | Times Cited: 52
3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study
Hui Zhang, Chaolin Huang, Xiaoying Gu, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 1, pp. 55-66
Open Access | Times Cited: 52
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
Fotini Boufidou, Snežana Medić, Vicky Lampropoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12962-12962
Open Access | Times Cited: 51
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
Kailin Yin, Michael J. Peluso, Xiaoyu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 47
Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data
Omar Yaxmehen Bello‐Chavolla, Carlos A. Fermín‐Martínez, Daniel Ramírez‐García, et al.
The Lancet Regional Health - Americas (2024) Vol. 30, pp. 100688-100688
Open Access | Times Cited: 24
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 64
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
Gabriella Captur, James Moon, Constantin‐Cristian Topriceanu, et al.
EBioMedicine (2022) Vol. 85, pp. 104293-104293
Open Access | Times Cited: 53
Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study
Hui Zhang, Xia Li, Lixue Huang, et al.
EClinicalMedicine (2022) Vol. 54, pp. 101668-101668
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top